Compare CORAL LAB. with LINK PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CORAL LAB. vs LINK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CORAL LAB. LINK PHARMA CORAL LAB./
LINK PHARMA
 
P/E (TTM) x 8.4 11.2 74.8% View Chart
P/BV x 0.8 1.4 56.5% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 CORAL LAB.   LINK PHARMA
EQUITY SHARE DATA
    CORAL LAB.
Mar-21
LINK PHARMA
Mar-20
CORAL LAB./
LINK PHARMA
5-Yr Chart
Click to enlarge
High Rs44326 1,711.6%   
Low Rs9510 966.4%   
Sales per share (Unadj.) Rs270.557.4 471.5%  
Earnings per share (Unadj.) Rs38.02.1 1,774.6%  
Cash flow per share (Unadj.) Rs43.54.2 1,029.0%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs382.825.8 1,486.4%  
Shares outstanding (eoy) m3.574.44 80.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.00.3 319.7%   
Avg P/E ratio x7.18.4 84.9%  
P/CF ratio (eoy) x6.24.2 146.5%  
Price / Book Value ratio x0.70.7 101.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m96279 1,212.1%   
No. of employees `000NANA-   
Total wages/salary Rs m10250 204.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m966255 379.1%  
Other income Rs m381 3,696.1%   
Total revenues Rs m1,003256 392.4%   
Gross profit Rs m16126 612.9%  
Depreciation Rs m209 213.7%   
Interest Rs m34 78.4%   
Profit before tax Rs m17614 1,222.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m415 826.5%   
Profit after tax Rs m13610 1,426.8%  
Gross profit margin %16.710.3 161.6%  
Effective tax rate %23.034.1 67.6%   
Net profit margin %14.03.7 376.4%  
BALANCE SHEET DATA
Current assets Rs m1,10891 1,220.3%   
Current liabilities Rs m27835 804.5%   
Net working cap to sales %86.022.1 389.2%  
Current ratio x4.02.6 151.7%  
Inventory Days Days13515 874.7%  
Debtors Days Days1,48072 2,068.2%  
Net fixed assets Rs m56799 573.6%   
Share capital Rs m3644 80.5%   
"Free" reserves Rs m1,33170 1,902.9%   
Net worth Rs m1,366114 1,195.2%   
Long term debt Rs m032 0.0%   
Total assets Rs m1,675190 883.3%  
Interest coverage x63.25.0 1,266.8%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.61.3 42.9%   
Return on assets %8.36.9 119.5%  
Return on equity %9.98.3 119.4%  
Return on capital %13.112.3 106.1%  
Exports to sales %72.30-   
Imports to sales %2.00-   
Exports (fob) Rs m698NA-   
Imports (cif) Rs m19NA-   
Fx inflow Rs m6981 52,120.1%   
Fx outflow Rs m310-   
Net fx Rs m6681 49,829.1%   
CASH FLOW
From Operations Rs m1130 37.8%  
From Investments Rs m-2-17 12.2%  
From Financial Activity Rs m36 54.1%  
Net Cashflow Rs m1218 65.7%  

Share Holding

Indian Promoters % 32.3 51.5 62.7%  
Foreign collaborators % 39.2 0.0 -  
Indian inst/Mut Fund % 0.4 0.0 2,100.0%  
FIIs % 0.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 28.5 48.5 58.7%  
Shareholders   4,237 5,706 74.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CORAL LAB. With:   AMRUTANJAN HEALTHCARE  ZANDU REALTY  RAYMED LABS  BHARAT PARENTALS  WINDLAS BIOTECH  



Today's Market

Sensex Zooms 777 Points, Nifty Ends Above 17,400; Power & IT Stocks Rally(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views on News

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CORAL LAB. SHARE PRICE


Dec 2, 2021 (Close)

TRACK CORAL LAB.

  • Track your investment in CORAL LAB. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

CORAL LAB. 8-QTR ANALYSIS

COMPARE CORAL LAB. WITH

MARKET STATS